C5a-Stimulated Recruitment of ß-Arrestin2 to the Nonsignaling 7-Transmembrane Decoy Receptor C5L2

Journal of Biomolecular Screening

Volumn 14, Issue 9, 2009, Pages 1067-1075

  Van Lith, Lambertus H c ^a   Oosterom, Julia ^a   Van Elsas, Andrea ^a   Zaman, Guido J r ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

C5a; C5L2; complement; GPCR; green fluorescent protein; galactosidase

Indexed keywords

BETA ARRESTIN; CHEMOKINE RECEPTOR; COMPLEMENT COMPONENT C5A; GPR77 PROTEIN, HUMAN; HYBRID PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RETINA S ANTIGEN;

ANIMAL; ARTICLE; CHO CELL; CRICETULUS; DOSE RESPONSE; GENETICS; HAMSTER; HUMAN; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ARRESTINS; CHO CELLS; COMPLEMENT C5A; CRICETINAE; CRICETULUS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; RECEPTORS, CHEMOKINE; RECOMBINANT FUSION PROTEINS; SIGNAL TRANSDUCTION;

EID: 74049118441     PISSN: 10870571     EISSN: None     Source Type: Journal    
DOI: 10.1177/1087057109341407     Document Type: Article

References (41)

1. Pierce KL, Premont RT, Lefkowitz RJ: Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002; 3: 639-650.
2. Seifert R., Wenzel-Seifert K.: Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg's Arch Pharmacol 2002; 366: 381-416.
3. Overington JP, Al-Lazikani B., Hopkins AL: How many drug targets are there? Nat Rev Drug Discov 2006; 5: 993-996.
4. Pitcher JA, Freedman NJ, Lefkowitz RJ: G protein-coupled receptor kinases. Annu Rev Biochem 1998; 67: 653-692.
5. Lohse MJ, Benovic JL, Codina J., Caron MG, Lefkowitz RJ: beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science 1990; 248: 1547-1550.
6. Laporte SA, Oakley RH, Zhang J., Holt JA, Ferguson SS, Caron MG, et al: The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis. Proc Natl Acad Sci USA 1999; 96: 3712-3717.
7. Tsao P., Cao T., von Zastrow M.: Role of endocytosis in mediating down-regulation of G-protein-coupled receptors. Trends Pharmacol Sci 2001; 22: 91-96.
8. Lefkowitz RJ, Shenoy SK: Transduction of receptor signals by betaarrestins. Science 2005; 308: 512-517.
9. Violin JD, Lefkowitz RJ: Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci 2007; 28: 416-422.
10. Wei H., Ahn S., Shenoy SK, Karnik SS, Hunyady L., Luttrell LM, et al: Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc Natl Acad Sci USA 2003; 100: 10782-10787.
11. Ahn S., Shenoy SK, Wei H., Lefkowitz RJ: Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. J Biol Chem 2004; 279: 35518-35525.
12. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Kang L., et al: Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 1996; 271: 19021-19024.
13. Zhang J., Ferguson SS, Law PY, Barak LS, Bodduluri SR, Laporte SA, et al: Role for G protein-coupled receptor kinase in agonist-specific regulation of mu-opioid receptor responsiveness. Proc Natl Acad Sci USA 1998; 95: 7157-7162.
14. Groer CE, Tidgewell K., Moyer RA, Harding WW, Rothman RB, Prisinzano TE, et al: An opioid agonist that does not induce Mu opioid receptor-arrestin interactions or receptor internalization. Mol Pharmacol 2007; 71: 549-557.
15. Monk PN, Scola A-M., Madala P., Fairlie DP: Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol 2007; 152: 429-448.
16. Lee H., Whitfield PL, Mackay CR: Receptors for complement C5a: the importance of C5aR and the enigmatic role of C5L2. Immunol Cell Biol 2008; 86: 153-160.
17. Rollins TE, Siciliano S., Kobayashi S., Chianciarulo DN, Bonilla-Argudo V., Collier K., et al: Purification of the active C5a receptor from human polymorphonuclear leukocytes as a receptor-Gi complex. Proc Natl Acad Sci USA 1991; 88: 971-975.
18. Gao H., Neff TA, Guo R-F., Speyer CL, Sarma JV, Tomlins S., et al: Evidence for a functional role of the second C5a receptor. FASEB J 2005; 19: 1003-1005.
19. Gerard NP, Lu B., Liu P., Craig S., Fujiwara Y., Okinaga S., et al: An antiinflammatory function for the complement anaphylatoxin C5a binding protein, C5L2. J Biol Chem 2005;280: 39677-39680.
20. Chen N-J., Mirtsos C., Suh D., Lu Y-C., Lin W-J., McKerlie C., et al: C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 2007; 446: 203-207.
21. Cain SA, Monk PN: The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a desArg. J Biol Chem 2002; 277: 7165-7169.
22. Okinaga S., Slattery D., Humbles A., Zsengeller Z., Morteau O., Kinrade MB, et al: C5L2, a nonsignaling C5A binding protein. Biochemistry 2003; 42: 9406-9415.
23. Kalant D., MacLaren R., Cui W., Samanta R., Monk PN, Laporte SA, et al: C5L2 is a functional receptor for acylation-stimulating protein. J Biol Chem 2005; 280: 23936-23944.
24. Johswich K., Martin M., Thalmann J., Rheinheimer C., Monk PN, Klos A.: Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines. J Biol Chem 2006; 281: 39088-39095.
25. Wehrman TS, Casipit CL, Gewertz NM, Blau HM: Enzymatic detection of protein translocation. Nat Methods 2005; 2: 521-527.
26. March DR, Proctor LM, Stoermer MJ, Sbaglia R., Abbenante G., Reid RC, et al: Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes: relationships between structures and activity. Mol Pharmacol 2004; 65: 868-879.
27. Oakley RH, Hudson CC, Cruickshank RD, Meyers DM, Payne RE Jr, Rhem SM, et al: The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors. Assay Drug Dev Technol 2002; 1: 21-30.
28. Verkaar F., van Rosmalen JWG, Blomenröhr M., van Koppen CJ, Blankesteijn WM, Smits JFM, et al: G protein-independent cell-based assays for drug discovery on seven-transmembrane receptors. Biotechnol Ann Rev 2008; 14: 253-274.
29. Olson KR, Eglen RM: Beta galactosidase complementation: a cell-based luminescent assay platform for drug discovery. Assay Drug Dev Technol 2007; 5: 137-144.
30. van der Lee MMC, Bras M., van Koppen CJ, Zaman GJR: β-arrestin recruitment assay for the identification of agonists of the sphingosine 1-phosphate receptor EDG1. J Biomol Screen 2008; 13: 986-998.
31. Kurose H., Katada T., Amano T., Ui M.: Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via α-adrenergic, cholinergic, and opiate receptors in neuroblastoma × glioma hybrid cells. J Biol Chem 1983; 258: 4870-4875.
32. Chen W., ten Berge D., Brown J., Ahn S., Hu LA, Miller WE, et al: Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science 2003; 301: 1391-1394.
33. Chen W., Ren XR, Nelson CD, Barak LS, Chen JK, Beachy PA, et al: Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2. Science 2004; 306: 2257-2260.
34. Oakley RH, Laporte SA, Holt JA, Caron MG, Barak LS: Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J Biol Chem 2000; 275: 17201-17210.
35. Braun L., Christophe T., Boulay F.: Phosphorylation of key serine residues is required for internalization of the complement 5a (C5a) anaphylotoxin receptor via a β-arrestin, dynamin, and clathrin-dependent pathway. J Biol Chem 2003; 278: 4277-4285.
36. Scola A-M., Johswich K-O., Morgan BP, Klos A., Monk PN: The human complement fragment receptor, C5L2, is a recycling decoy receptor. Mol Immunol 2009; 46: 1149-1162.
37. Locati M., Torre YM, Galliera E., Bonecchi R., Vago G., Vecchi A., et al: Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines. Cytokine Growth Factor Rev 2005; 16: 679-686.
38. Galliera E., Jala VR, Trent JO, Bonecchi R., Signorelli P., Lefkowitz RJ, et al: β-arrestin-dependent consitutive internalization of the human chemokine decoy receptor D6. J Biol Chem 2004; 279: 25590-25597.
39. Chakera A., Seeber RM, John AE, Eidne KA, Greaves DR: The Duffy antigen/receptor for chemokines exists in an oligomeric form in living cells and functionally antagonizes CCR5 signaling through hetero-oligomerization. Mol Pharmacol 2008; 73: 1362-1370.
40. Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD: Defective lymphocyte chemotaxis in β-arrestin2 and GRK6-deficient mice. Proc Natl Acad Sci USA 2002; 99: 7478-7483.
41. Walker JKL, Fong AM, Lawson BL, Savoj JD, Patel DD, Schwartz DA, et al: β-arrestin-2 regulates the development of allergic asthma. J Clin Invest 2003;112: 566-574.